Alastair Lamb (@lambalastair) 's Twitter Profile Photo

Really great to see details re #TRANSFORM_Trial from Hashim U. Ahmed during Nuffield Department of Surgical Sciences #SurgicalGrandRounds 3 stages: #1 Pilot 4 intervents (3yrs) #2 Recruit 300k (6yrs) #3 LT follow up (10yrs) Zelen design (like CAP) Exciting times ahead! (Slightly scary MRI numbers!!)

Really great to see details re #TRANSFORM_Trial from <a href="/LondonProstate1/">Hashim U. Ahmed</a> during <a href="/NDSurgicalSci/">Nuffield Department of Surgical Sciences</a> #SurgicalGrandRounds

3 stages:
#1 Pilot 4 intervents (3yrs)
#2 Recruit 300k (6yrs)
#3 LT follow up (10yrs)

Zelen design (like CAP)

Exciting times ahead!

(Slightly scary MRI numbers!!)
Alastair Lamb (@lambalastair) 's Twitter Profile Photo

Wonderful overview of 20 amazing yrs of #ProstateCancer research from @MrsProstate #NDSAwayDay2024 Transformative developments in prostate diagnostics, MRI and Focal Tx. And huge potential to shift the paradigm in #PCa screening with #TRANSFORM_Trial Prostate Cancer UK National Institute for Health and Care Research

Wonderful overview of 20 amazing yrs of #ProstateCancer research from @MrsProstate #NDSAwayDay2024

Transformative developments in prostate diagnostics, MRI and Focal Tx. And huge potential to shift the paradigm in #PCa screening with #TRANSFORM_Trial <a href="/ProstateUK/">Prostate Cancer UK</a> <a href="/NIHRresearch/">National Institute for Health and Care Research</a>
Razan Mohty (@razan_mohty) 's Twitter Profile Photo

#Transform_trial liso_cel shows better EFS, CR rate, signal of better OS despite crossover and acceptable safety profile #ASHKudos Dr Kamdar #ASH21 Mohamad Mohty ASH

#Transform_trial liso_cel shows better EFS, CR rate, signal of better OS despite crossover and acceptable safety profile #ASHKudos Dr Kamdar #ASH21 <a href="/Mohty_EBMT/">Mohamad Mohty</a> <a href="/ASH_hematology/">ASH</a>